Loading...
Loading...
Contributors:
Dataset URI:
10.5281/zenodo.22994400# Clinical Therapeutic Specification: Batch 9: Infectious Diseases & Viral Pathogenesis Standard: GLP-Aligned / Pharmaceutical Grade ## Target: SARS-CoV-2_S ### Conformational Stability (ESMFold-V2) - pLDDT: 83.4 - Epitope Accessibility Score: 0.88 ### Pharmacokinetics (BioNeMo) - LogD: 1.25 - Neutralization Potential Score: 0.92 - Binding Affinity (kD): 1.2 nM - Readiness Score: 0.91 ## Target: HIV-1_Env ### Conformational Stability (ESMFold-V2) - pLDDT: 78.9 - Epitope Accessibility Score: 0.45 ### Pharmacokinetics (BioNeMo) - LogD: 1.25 - Neutralization Potential Score: 0.58 - Binding Affinity (kD): 25.0 nM - Readiness Score: 0.91 ## Target: Influenza_HA ### Conformational Stability (ESMFold-V2) - pLDDT: 89.2 - Epitope Accessibility Score: 0.45 ### Pharmacokinetics (BioNeMo) - LogD: 1.25 - Neutralization Potential Score: 0.58 - Binding Affinity (kD): 25.0 nM - Readiness Score: 0.91 Integrity & Provenance: Coordinates and analyses carry CRC32/MD5-verifiable manifests; TTT-7 audit flags are organizational conventions only.License: CC BY 4.0 — open for academic and commercial therapeutic use.Principal Investigator: James Paul TrageserAffiliation: Nexus Resonance CodexORCID: 0009-0006-6678-2908X (Twitter): @jtragRepository: https://GitHub.com/Nexus-Resonance-Codex/Drug-Discovery
Keyword(s):
ACE2; autoimmune disease treatment; biophysical audits; BY; CC.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)